SIREN : 418660924
BIOTEK PARTENAIRES is a French company founded 28 years ago, specialized in the sector Activités des sociétés holding. Based in LYON (69006), this company of category PME shows in 2024 a net income positive of 3.5 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | N/C | N/C | N/C | N/C | N/C | N/C |
| Net income | 3 523 796 € | 3 010 561 € | 2 838 764 € | 2 796 191 € | 2 583 027 € | 2 434 756 € | 1 746 895 € | 2 457 989 € | 1 761 794 € |
| EBITDA | -139 € | -40 € | -96 € | -146 € | -47 € | -98 € | -844 € | -5 739 € | -18 € |
| Net margin | N/C | N/C | N/C | N/C | N/C | N/C | N/C | N/C | N/C |
In 2024, BIOTEK PARTENAIRES generates positive net income of 3.5 M€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 1.8 M€ -> 3.5 M€.
-139 €
-139 €
3 523 796 €
The debt ratio (= Financial debt / Equity x 100) stands at 30%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 77%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 1.0 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability.
29.848%
77.013%
0.956
In 2024, the debt ratio of BIOTEK PARTENAIRES (29.85) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of BIOTEK PARTENAIRES (77.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2024, the repayment capacity of BIOTEK PARTENAIRES (0.96) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
-1033039.568
In 2024, the interest coverage of BIOTEK PARTENAIRES (-1033039.6x) ranks in the bottom 25% of the sector. This ratio indicates how many times operating income covers interest expenses. Low coverage may indicate fragility to rate or income variations.
Based on 54 transactions of similar company sales
in 2024,
the value of BIOTEK PARTENAIRES is estimated at
5 144 608 €
(range 3 281 143€ - 26 317 335€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 54 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare BIOTEK PARTENAIRES with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sociétés holding
The revenue of BIOTEK PARTENAIRES is not publicly disclosed (confidential accounts filed with INPI).
Yes, BIOTEK PARTENAIRES generated a net profit of 3.5 M€ in 2024.
The headquarters of BIOTEK PARTENAIRES is located in LYON (69006), in the department Rhone.
The tax return of BIOTEK PARTENAIRES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
BIOTEK PARTENAIRES operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.